Apremilast is a prescription tablet used to treat long-lasting inflammatory conditions of the skin and joints. It contains a single active ingredient that belongs to a group of medicines called phosphodiesterase 4 (PDE4) inhibitors. Doctors prescribe it for psoriatic arthritis (joint pain and swelling linked to psoriasis), plaque psoriasis (red, scaly skin patches), and painful mouth ulcers caused by Behcet's disease. Apremilast works inside immune cells to calm the signals that drive inflammation. It helps control these conditions over time rather than making them go away for good, so it is usually taken every day for as long as your doctor advises.
Apremilast is a medicine taken by mouth. It blocks an enzyme called phosphodiesterase 4 (PDE4), which is found inside immune cells. When this enzyme is blocked, levels of a messenger molecule called cyclic AMP (cAMP) rise inside the cell. Higher cAMP levels turn down the release of several inflammatory chemicals, including TNF-alpha, IL-12 and IL-23. In people treated with Apremilast, blood levels of IL-17, IL-22 and TNF-alpha have been seen to fall. Because it acts on the inflammation process itself, Apremilast is used in conditions where the immune system is overactive.
In adults, Apremilast is approved for active psoriatic arthritis, plaque psoriasis in people who are candidates for light therapy (phototherapy) or whole-body treatment, and mouth ulcers linked to Behcet's disease. The current US label also allows its use in children aged 6 years and older who weigh at least 20 kg, for psoriatic arthritis and moderate to severe plaque psoriasis.
One practical difference from many other treatments for these conditions is that Apremilast is a tablet, not an injection. It also does not need routine blood test monitoring, which some patients find easier for long-term care.
Treatment is started at a low dose and slowly raised over the first 5 days. This step-up helps reduce stomach upset, which is the most common problem people notice early on. Diarrhoea, nausea and vomiting can sometimes be severe, and in some cases people have needed hospital care. Most of these events happen within the first few weeks.
Apremilast has also been linked to depression and weight loss. Your doctor will ask about your mental health history before you start, and will check your weight during treatment. For these reasons, Apremilast should only be used under the care of a doctor who can review how you are doing at regular visits.
Each tablet contains Apremilast as its only active ingredient. The regular tablets are made in strengths of 10 mg, 20 mg and 30 mg, and a starter pack with the lower strengths is used during the first days of treatment. In the US, an extended-release (long-acting) tablet of 75 mg is also approved for once-daily use. Chemically, Apremilast belongs to the isoindole class of compounds.
Apremilast is used to treat the following conditions:
Common Side Effects (Usually Mild and may lessen with continued use)
Serious Side Effects (Seek Urgent Medical Attention)
Inside many immune cells there is an enzyme called phosphodiesterase 4, or PDE4. An enzyme is a protein that speeds up a chemical reaction. The job of PDE4 is to break down a messenger molecule called cyclic AMP (cAMP).
cAMP acts like a brake on inflammation inside the cell. When cAMP levels are high, the cell makes fewer inflammatory chemicals. When PDE4 breaks cAMP down, that brake is released and inflammation can build up.
Apremilast is a selective PDE4 inhibitor, which means it blocks this one enzyme. With PDE4 blocked, cAMP is not broken down as quickly, so its level inside the cell rises. This lowers the production of inflammatory messengers such as TNF-alpha, IL-2, IL-8, IL-12 and IL-23. These messengers, called cytokines, are signals the immune system uses to call in more inflammation. In people treated with Apremilast, blood levels of IL-17, IL-22 and TNF-alpha have been seen to fall.
The exact way these changes lead to improvement in psoriasis, psoriatic arthritis and Behcet's mouth ulcers is still being studied. What is clear is that Apremilast works by calming the overactive immune signals that drive these conditions, rather than by relieving pain directly.
Once swallowed, about 73% of the dose is absorbed, and blood levels peak in about 2.5 hours. The liver breaks it down, mainly through an enzyme called CYP3A4, and its half-life (the time for the body to clear half of it) is about 6 to 9 hours.
Unsafe. The European product information states that Apremilast must not be used during pregnancy. Pregnancy should be ruled out before treatment starts, and women who can become pregnant should use an effective method of contraception during treatment. Animal studies showed a higher risk of pregnancy loss. Tell your doctor if you are pregnant or planning a pregnancy, and call your doctor right away if you become pregnant while taking it.
Not recommended. It is unknown whether Apremilast passes into human breast milk, but it has been found in the milk of lactating mice, and women who are breastfeeding should not receive it. Discuss feeding options with your doctor.
The prescribing label does not list a specific interaction between Apremilast and alcohol. Because stomach upset and diarrhoea are its most common side effects, ask your doctor whether drinking is suitable for you.
According to the European product information, Apremilast has no or very little effect on the ability to drive or use machines. If you have headache or tiredness, wait until you feel alert before driving or using machines.
Use with caution. No dose change is needed for mild or moderate kidney problems. In severe kidney disease (creatinine clearance, a measure of how well the kidneys filter blood, below 30 mL/min), the label lowers the regular tablet to once a day - 30 mg once daily in adults and children weighing 50 kg or more, or 20 mg once daily in children weighing 20 kg to less than 50 kg. The extended-release tablet is not recommended in severe kidney disease.
The label states no dose change is needed in moderate or severe liver impairment. Liver enzyme rises during treatment are uncommon.
Approved for children aged 6 years and older who weigh at least 20 kg, for psoriatic arthritis and moderate to severe plaque psoriasis. The extended-release tablet is only for children who weigh at least 50 kg. The doctor will closely monitor height and weight, and treatment may be paused if a child is not growing or gaining weight as expected.
The label reports no overall difference in safety for people aged 65 and older. However, older adults may be at higher risk of complications such as fluid loss from severe diarrhoea or vomiting, so they should be watched closely.
Do not take Apremilast if you are allergic to it or to any ingredient in the tablet. Serious allergic reactions, including swelling of the face, lips, tongue or throat, have been reported.
Always take the dose your doctor prescribes. Do not change or stop your dose on your own.
If you think you or someone else has taken too much Apremilast, contact your doctor or a poison control centre right away. The European product information notes that in a short study, healthy volunteers were given up to 100 mg a day (50 mg twice a day) for 4.5 days without side effects severe enough to stop the study dose. In case of an overdose, doctors watch closely for any signs of side effects and treat symptoms as they appear with supportive care. If the person has collapsed or has trouble breathing, call emergency services immediately. Take the medicine pack with you to the hospital so the doctors know what was taken.
Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and carry on with your usual schedule. Do not take a double dose to make up for a missed one.
Contact your doctor or get emergency help right away if you notice:
Therapeutic Class
Antipsoriatic and anti-inflammatory agent
Action Class
Phosphodiesterase 4 (PDE4) inhibitor
Chemical Class
Isoindole (isoindole-1,3-dione) derivative
Habit Forming
No
Checkout Editorial Policy
Top Selling Medicines
Top Health Products
Top Selling Devices
Apremilast 30mg

₹304.7

₹141.5
MRP ₹283
Apremilast 30mg

₹193.4

₹141.5
MRP ₹283
Apremilast 10mg

₹98.6

₹28.5
MRP ₹50
Apremilast 10mg

₹193.1

₹28.5
MRP ₹50
Apremilast 30mg

₹255.9

₹141.5
MRP ₹283
Apremilast 30mg

₹305.6

₹141.5
MRP ₹283
Apremilast 20mg

₹125.5

₹51.6
MRP ₹86
Apremilast 30mg

₹335

₹141.5
MRP ₹283
Apremilast 30mg

₹250

₹141.5
MRP ₹283
Apremilast 30mg

₹240

₹141.5
MRP ₹283
Apremilast 20mg

₹113.4

₹51.6
MRP ₹86
Apremilast 20mg

₹187.5

₹51.6
MRP ₹86
Apremilast 20mg

₹170

₹51.6
MRP ₹86
Apremilast 10mg

₹140.6

₹28.5
MRP ₹50
Apremilast 20mg

₹113.4

₹51.6
MRP ₹86
Apremilast 30mg

₹346.9

₹141.5
MRP ₹283
Apremilast 10mg

₹28.5
MRP ₹50
Apremilast 30mg

₹281.3

₹141.5
MRP ₹283
Apremilast 30mg

₹330

₹141.5
MRP ₹283
Apremilast 10mg

₹45

₹28.5
MRP ₹50
Apremilast 30mg

₹103.1

₹141.5
MRP ₹283
Apremilast 10mg

₹187.5

₹28.5
MRP ₹50
Apremilast 30mg

₹450

₹141.5
MRP ₹283
Apremilast 10mg + Apremilast 20mg + Apremilast 30mg

₹295

Apremilast 10mg + Apremilast 20mg + Apremilast 30mg

₹182.8
